Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Chiara Bucciarelli-Ducci,
Dear Friends and Colleagues
A great meeting cannot conclude without an amazing Closing Plenary session with an outstanding and distinguish faculty.
The session will explore the role of CMR in risk stratification for sudden cardiac death encompassing both cardiomyopathic substrates but also athletic heart. Prof Corrado’s talk will review the clinical, genetic, and imaging Task Force criteria then focusing on the added value of CMR. He will also explore the role of late gadolinium enhancement (LGE) currently not included in the Task Force Criteria and possibly exploring if any change/implementation might be expected in the next revision.
Prof Sharma will take us to the world of competitive athletes, exploring the challenges that anatomical and physiological adaptation to exercise brings in the diagnosis of athletic heart vs cardiomyopathy, and how CMR can make the difference.
Prof Olivotto will share his clinical experience in patients with hypertrophic cardiomyopathy, critically appraising the role of CMR in these patients, and the added value vs echocardiography, as well as exploring the somewhat controversial limited value of LGE in the 2014 ESC guidelines in HCM.
Prof Basso will bring the perspective of the anatomic pathologist educating us on the anatomical and functional substrates of sudden cardiac death and the limitations and opportunity of imaging, and CMR in particular, in identifying these non invasively.
Don’t miss this session! It will be your opportunity to ask those experts your clinical relevant questions in the management of these challenging patients.
Last but not least, see you in Prague in 2017!
EuroCMR 2016 was a record meeting with new exciting features that received overwhelming positive feedback from attendees this year. Much more is expected new year including new features and a lot of surprises!